Safety and efficacy of a novel temporary sternal spreader in the management of severe postcardiotomy cardiogenic shock: A preliminary report study  by Santini, Francesco et al.
Brief Technique ReportsSafety and efficacy of a novel temporary sternal spreader in the
management of severe postcardiotomy cardiogenic shock:
A preliminary report studyFrancesco Santini, MD, Francesco Onorati, MD, Giuseppe Faggian, MD, and Alessandro Mazzucco, MD,
Verona, ItalyOpen chest management (OCM) with delayed sternal
closure (DSC) is a valuable tool to manage patients with
postcardiotomy hemodynamic instability related to cardio-
genic shock with myocardial and lung edema and/or severe
coagulopathy.1-4
OCM traditionally involves the use of plastic material
(generally a syringe) acting as a stent between the 2 hemi-
sternal halves, with the purposes to maintain the chest
open to prevent compression and to avoid traumatic
injuries on the underlying mediastinal structures.1-4 The
use of these ‘‘passive’’ plastic stents, however, is linked
to the ‘‘all or nothing’’ rule, which makes the decision
on stent removal and chest closure tricky and
potentially associated with a renewed hemodynamic
instability.4 The risk for passive stent dislocation with po-
tential sternal fracture or mediastinal injury has also been
reported.1-5
We tested a new device for temporary sternal stent-
ing, the Temporary Sternal Spreader (TSS; Futura Engi-
neering, Cerbara, PG, Italy), which allows ‘‘closed’’
remote spreading variations over time until complete re-
approximation of the sternal halves is accomplished,
while keeping the wound continuously covered by
a sterile elastic membrane. The trial was coupled
with continuous hemodynamic monitoring to titrate
sternal reapproximation on objective hemodynamic
improvements.CLINICAL SUMMARY
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refractory postcardiotomy cardiogenic shock (cardiac
index< 1.5  0.2 L $ min1 $ m2) with acute hemody-
namic instability at any attempt to close the chest. The
new TSS was implanted in these patients. All patients
shared preoperative ventricular dysfunction (mean ejection
fraction 38.2%  7%), pulmonary hypertension (mean
pulmonary artery pressures 57 5 mm Hg), and prolonged
intraoperative cardiopulmonary bypass time (147.3  51.4
minutes).
The newly conceived TSS consists of stainless steel
branches linked to 2 diverging plates of polyether ether
ketone fixed to the sternal edges by interrupted sutures,
whose progressive opening/closing mechanism is con-
trolled from outside the chest by a rotating steel wire
passed through the skin inside a conventional chest tube
drain (Figure 1, A, B, and C). The external rotating steel
wire approximates (clockwise rotation) or spreads (coun-
terclockwise rotation) the sternal plates, allowing a maxi-
mal distance between the 2 diverging plates of 12 cm
(Figure 2). TSS implantation was completed by wound
coverage with a sterile membrane (Gore-Tex membrane
[W. L. Gore & Associates, Inc, Flagstaff, Ariz] or Esmark
membrane [Northern Steel Group, Inc, Chicago Heights,
Ill]) sutured to the skin edges. A Swan-Ganz catheter (Ed-
wards LifeSciences, Irvine, Calif) was used to monitor
progressive hemodynamic recovery (cardiac index  2.1
L $ min1 $ m2) and titrate ‘‘closed-remote’’ reapproxi-
mation of the sternal halves until virtual closure, consid-
ered a prerequisite for final sternal rewiring in all cases.
A procedural success was defined as a complete reapprox-
imation of the sternal halves with subsequent uneventful
sternal closure and no need for implementation of inotro-
pic support.RESULTS
The procedurewas successful in all patients without tech-
nical or infective complications (mean distance of intrao-
perative sternal spreading 10.8  0.8 cm). Mean time
from TSS implantation to sternal closure was 67 24 hours
(range, 49–93 hours). One patient showing worsening he-
modynamic performance during progressive closure needed
a 2-cm ‘‘remote’’ respreading to reestablish a stablegery c November 2011
FIGURE 1. A, The TSS device (low profile spreader, rotating arm, handle). All the components are stainless steel or polyether ether ketone. The holes at the
level of the sternal plates allow the device to be secured to the sternum. B, Clockwise rotation of the steel arm (curved arrow) approximates the sternal plates
(straight arrows). C, Counterclockwise rotation of the steel arm (curved arrow) spreads the sternal plates (straight arrows).
Brief Technique Reportshemodynamic condition. He underwent a new successful
reapproximation trial 24 hours later. All patients underwent
sternal closure and rewiring in the intensive care unit with
no evidence of late hemodynamic instability. There was 1
(20%) hospital death resulting from multiorgan failure on
postoperative day 9.FIGURE 2. In vivo application of the TSS. Note the low profile of the
spreader, which allows covering of the surgical wound by a membrane
(Gore-Tex membrane [W. L. Gore & Associates, Inc, Flagstaff, Ariz] in
this case) with no bulging effect (inset).
The Journal of Thoracic and CarAll other patients were discharged to a rehabilitation unit.
Length of intensive care unit and in-hospital stay were 197
 49 hours and 16  9 days, respectively.DISCUSSION
OCM with DSC reported use has reached about 4%
of all cardiac cases and is thought to rise further accord-
ing to a worsening referral.4,5 Currently, the use of
extemporized stents made of disposable plastic
materials (syringes) not approved by the Food and Drug
Administration or by European CE marking is the
most used method worldwide despite recognized
limitations.1,3-5 The new TSS proved to be safe with no
cases of sternal lesions, dislocation-related right ventricu-
lar or mediastinal injuries, or infections. Most important,
the new device proved able to accommodate the progres-
sive sternal closure to the patient-monitored hemody-
namic status versus the ‘‘all or nothing’’ rule of other
extemporized stents. Indeed, the ‘‘closed-remote’’ exter-
nal control to achieve progressive sternal reapproximation
(or spreading, if necessary) proved a very valuable tool to
titrate the DSC strategy on the patient’s hemodynamic
improvement, also reducing the risk for mediastinal bac-
terial contamination by limiting the need for repeated
wound dressing.
A less extemporized used of the OCM/DSC strategy in
view of the availability of more sophisticated tools might
allow the use of this technique to be extended to some
of those patients currently managed by implantation of
ventricular assist devices, for whom a less aggressive
approach might be indicated with the advantage ofdiovascular Surgery c Volume 142, Number 5 1277
Brief Technique Reportspreventing the potentially dismal drawbacks of mechani-
cal assistance.
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7:801-4.Papillary muscle–to–anterior annulus stitches: Another
technique to prevent systolic anterior motion after mitral
valve repairSamer Kassem, MD,a and Hicham Jamil, MD,b Milan, Italy, and Damascus, SyriaMitral valve reconstruction is the procedure of choice for
mitral regurgitation, with excellent early and late results.1
Systolic anteriormotion (SAM)may occur aftermitral valve
reconstruction as a result of various anatomic factors, such
as degenerative mitral insufficiency with excessive leaflet
tissue, nondilated left ventricular cavity, narrow mitroaortic
angle, and anterior displacedmitral coaptation line.2,3 SAM,
and consequent left ventricular outflow tract obstruction,
occurs in more than 16% of patients after mitral valve
repair.2,3 In this report, we describe a new method to
prevent the occurrence of SAM after mitroplasty. Two
artificial chords are subsequently implanted in the
posterior and anterior papillary muscles, then anchored to
the midanterior mitral annulus to keep the anterior leaflet
away from the septum during late diastole, to prevent its
displacement into the left ventricle outflow tract during
systole.SURGICAL TECHNIQUE
The inspection of the mitral valve is carried out as usual.
The leaflets are accurately analyzed, and the papillary
muscles are inspected to identify the posterior head of
each papillary muscle. A double-armed 4-0 polytetrafluoro-
ethylene (Gore-Tex; W. L. Gore & Associates, Flagstaff,
Ariz) suture supported by a felt pledget is passed twice
through the tip of the posterior head of the posterior pap-
illary muscle with a forehand technique and is fixed with
a loose knots to avoid necrosis (Figure 1, A). The ventric-
ular surface of the anterior leaflet is inspected with two
nerve hooks to explore the attachment of 1 secondary
chord, which arises from the posterior papillary muscle
(preferably the most distant from the leaflet’s board, and
toward the mitral anteroposterior axis) (Figure 1, A). The
height of the selected chord is used as a guide for deter-
mining the length of the first part of the new chord. A
metal clip is placed across the 2 arms of the new chord
at the level of the anchor of the stretched native chord se-
lected (Figure 1, A). The trace of the attachment of the se-
lected chord on the atrial surface of the anterior leaflet is
determined by insertion of a thin insulin needle as a marker
beside the attachment’s site. Thereafter, the anterior leaflet
is once again pulled down into the ventricular cavity, leav-
ing the insulin needle in place (Figure 1, B). On the atrial
surface of the anterior leaflet, the distance between the
marker (the insulin needle) and the anterior annulus deter-
mines the length of the second part of the new chord,
which will be anchored to the anterior annulus with no ex-
cessive tension during the presystolic phase. Multiplegery c November 2011
